Ulf Wiinberg - 01 Dec 2023 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact
Issuer symbol
INKT
Transactions as of
01 Dec 2023
Net transactions value
+$15,001
Form type
4
Filing time
05 Dec 2023, 18:05:07 UTC
Previous filing
17 Nov 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Award $15,001 +14,424 +24% $1.04 74,543 01 Dec 2023 Direct F1
holding INKT Common Stock 278,300 01 Dec 2023 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
F2 Shares are held in an irrevocable trust for the benefit of Mr. Wiinberg's family.